Andrea Crotti

Andrea Crotti

Company: Arrakis Therapeutics

Job title: Associate Director

Seminars:

Microglial Emerging Therapies & Targets under Clinical Trial for Neurodegenerative & Neuropsychiatric Disorders 12:00 pm

Analyzing the effectivity of anti TREM2 and anti CD33 agonist antibodies currently in clinical trial to improve understanding of the neuroimmunological aspects of Alzheimer’s disease Looking at small molecule P2X7 receptor antagonist, currently in Phase II clinical trial, to enhance knowledge surrounding the neuroimmunological aspects of Major Depressive Disorder Delving into small molecule RIPK1 inhibitor,…Read more

day: Day Two

Panel Discussion: Targets for Neuroinflammation 10:00 am

An interactive session to allow speakers to discuss different methods of targeting neuroinflammation Delving into the successes and downfalls and different targets, and their effectivity for different neurodegenerative disease profiles Looking towards future targets for neuroinflammation for both neurodegeneration and neuropsychiatric disordersRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.